Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 180

Results For "UP"

7696 News Found

FDA nod to Acrotech's new eczema treatment
Drug Approval | February 14, 2026

FDA nod to Acrotech's new eczema treatment

ADQUEY’s approval opens the door to a new alternative for millions of Americans struggling with atopic dermatitis


Citius Oncology expands LYMPHIR access across Europe via exclusive Uniphar deal
Supply Chain | February 14, 2026

Citius Oncology expands LYMPHIR access across Europe via exclusive Uniphar deal

Under the deal, Uniphar will serve as LYMPHIR’s exclusive distribution partner across designated Western and Eastern European territories


Precision BioSciences cleared by FDA to launch groundbreaking Duchenne gene editing trial
Clinical Trials | February 14, 2026

Precision BioSciences cleared by FDA to launch groundbreaking Duchenne gene editing trial

PBGENE-DMD is designed to permanently correct mutations in the dystrophin gene between exons 45 and 55, the “hot-spot” region affecting roughly 60% of DMD patients


BioAsia 2026 positions Telangana as a global TechBio powerhouse
News | February 14, 2026

BioAsia 2026 positions Telangana as a global TechBio powerhouse

BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem


Zota Health Care expands Davaindia network to 2,502 stores nationwide
News | February 13, 2026

Zota Health Care expands Davaindia network to 2,502 stores nationwide

The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year


Biocon posts strong Q3FY26 growth, boosted by biosimilars & generics
News | February 13, 2026

Biocon posts strong Q3FY26 growth, boosted by biosimilars & generics

Profit before tax jumped 64% to Rs. 226 crore, while the company maintained robust investment in innovation with net R&D spend of Rs. 249 crore


Alkem MedTech to acquire 55% stake in Switzerland's Occlutech for €99.4M
Medical Device | February 13, 2026

Alkem MedTech to acquire 55% stake in Switzerland's Occlutech for €99.4M

Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure


Moderna signs five-year strategic mRNA vaccine pact with Mexico
News | February 12, 2026

Moderna signs five-year strategic mRNA vaccine pact with Mexico

Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security